Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9JW2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,889
Award facts
- Contract value 100% obligated
- $23,889.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,889.28 delivery order to Amerisourcebergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 6, 2026, for the supply of IMFINZI (atezolizumab) 500 mg/10 mL vials. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 28, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. IMFINZI is a checkpoint inhibitor immunotherapy used to treat various cancers, including non-small cell lung cancer and urothelial carcinoma, making this order part of the federal government's pharmaceutical procurement for military healthcare systems.
This delivery order is executed under Amerisourcebergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling the contractor to supply a wide range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally. As a leading pharmaceutical distributor with established relationships across federal agencies including the Defense Health Agency and U.S. Coast Guard, Amerisourcebergen demonstrates the capability to efficiently fulfill specialized pharmaceutical procurement requirements through this flexible contracting mechanism.
Quick answers
Who was awarded contract SPE2DR26F9JW2?
SPE2DR26F9JW2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9JW2 worth?
The government has obligated $23,889 on SPE2DR26F9JW2.
Is contract SPE2DR26F9JW2 an order under another contract?
Yes. SPE2DR26F9JW2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JW2 competed?
The extent of competition for SPE2DR26F9JW2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award